about our company
Driven by the Challenges.
Inspired by the Potential.
Recombinetics is a privately-held bio venture company focused on solving some of the world’s most intractable challenges through gene editing.
through our ventures, we are:
- Transforming the world across agricultural markets by developing and deploying safe and effective tools for these applications.
- Using groundbreaking technology to improve and accelerate preclinical testing, making safer, more effective therapies.
- Spearheading the improvement of patient outcomes in the field of organ transplantations and regenerative medicine.


our story
From Innovator to Leader
Founded in 2008, Recombinetics focused its early-stage development on the application of precision genetic technologies in animals and active patent filings. Development of advanced gene-editing technologies for commercial purposes began in 2011.
Today, Recombinetics is widely recognized as the leader in livestock gene-editing and associated applied technologies for biomedical research, regenerative medicine, and animal agriculture.
We have a rich history as innovators and early adopters of molecular tools and methods for animal gene editing. When paired with our experienced teams focused on bioinformatics, cell engineering, embryology, stem cell biology, and animal husbandry, we’re able to add value to livestock and make pivotal changes in human health and longevity.
Recombinetics’ first gene-edited animals are generating revenues today with a pipeline of animals under development for the large biomedical and food animal markets.
a company of firsts
peer-reviewed science
Our scientific findings are often published in peer-reviewed scientific journals and often cited by other scientists in their published research. Our work has been documented in over 300 peer-reviewed publications and written been covered many times by both scientific and consumer media outlets.